Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Taylor Morrisette's publication output changed over time?
ScholarIQpublication output · 2019–2026
Output declined75% over the shown period — from 4 works in 2019 to 1 in 2026.
4
3
1
1
1
1
201920202021202220232026
What are the most-cited papers on Taylor Morrisette?
ScholarIQmost cited works
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Abdalhamid M Lagnf, Sahil Bhatia, Sarah Melvin, Molly E. Steed, Samuel Simon, S. J. Estrada, Taylor Morrisette, Kimberly C. Claeys, Joshua Rosenberg, Susan L. Davis, Michael J. Rybak
Open Forum Infectious Diseases. 2019138 CitationsOPEN ACCESS
Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations
Taylor Morrisette, Razieh Kebriaei, Katherine L. Lev, Sandra Morales, Michael J. Rybak
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 2019100 Citations
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Taylor Morrisette, Matthew A. Miller, Brian T. Montague, Gerard R. Barber, R. Brett McQueen, Martin Kršák
S124275759. 201992 Citations
Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
Taylor Morrisette, Matthew A. Miller, Brian T. Montague, Gerard R. Barber, R. Brett McQueen, Martin Kršák
Open Forum Infectious Diseases. 201966 CitationsOPEN ACCESS
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus
Razieh Kebriaei, Katherine L. Lev, Taylor Morrisette, Kyle Stamper, Jacinda C. Abdul‐Mutakabbir, Susan M. Lehman, Sandra Morales, Michael J. Rybak
Antimicrobial Agents and Chemotherapy. 202066 CitationsOPEN ACCESS
Related on ScholarIQ
Eugene Applebaum College of Pharmacy and Health Sciences
Institution
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
Paper
Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations
Paper
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
Paper
Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs
Paper
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus
Paper